Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic
2020; Lippincott Williams & Wilkins; Volume: 142; Issue: 3 Linguagem: Inglês
10.1161/circulationaha.120.048180
ISSN1524-4539
AutoresAlice K. Jacobs, Murtuza J. Ali, Patricia J.M. Best, Mark C. Bieniarz, Mauricio G. Cohen, William J. French, Gregg C. Fonarow, Christopher B. Granger, Abhinav Goyal, Timothy D. Henry, Lori Hollowell, Hani Jneid, James G. Jollis, Jason N. Katz, Peter Mason, Venu Menon, Michael Redlener, Jacqueline E. Tamis‐Holland, Jessica K. Zègre‐Hemsey,
Tópico(s)Mechanical Circulatory Support Devices
ResumoHomeCirculationVol. 142, No. 3Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBTemporary Emergency Guidance to STEMI Systems of Care During the COVID-19 PandemicAHA’s Mission: Lifeline and The American Heart Association’s Mission: Lifeline and Get With The Guidelines Coronary Artery Disease Advisory Work Group and the Council on Clinical Cardiology’s Committees on Acute Cardiac Care and General Cardiology and Interventional Cardiovascular Care* Originally published2 May 2020https://doi.org/10.1161/CIRCULATIONAHA.120.048180Circulation. 2020;142:199–202Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: May 2, 2020: Ahead of Print The American Heart Association (AHA) Get With The Guidelines Coronary Artery Disease Advisory Work Group, and the Acute Care and Interventional Science Subcommittees of the AHA Council on Clinical Cardiology, are responding to the call of concern on ideal ST-segment–elevation myocardial infarction (STEMI) Systems of Care during the coronavirus disease 2019 (COVID-19) pandemic. Emergency interim guidance is being provided, pivoting from the conventional AHA evidence-based meticulous peer review process. This statement addresses STEMI Systems of Care issues throughout the pandemic, to ensure that patients with STEMI continue to receive life-saving treatments while maintaining patient and healthcare worker safety.COVID-19 and STEMIMission: Lifeline is the American Heart Association’s national initiative to advance the systems of care for patients with STEMI.1 Under normal operative conditions, a STEMI system of care requires constant oversight and data review to manage continuous quality improvement. As a result of the COVID-19 pandemic, disruptions in the most refined systems of care have occurred.Delays are anticipated across the continuum of STEMI care. US hospitals are reporting substantial declines in patients presenting by emergency medical services (EMS) or by direct presentation with STEMI.2 Patients and family members may be less likely to call 911 for cardiac symptoms because of fear of exposure to the coronavirus. It is also plausible that there is a protective effect of sheltering, improved behaviors, and increased family support. More EMS-transported patients are expected to be critically ill requiring mechanical ventilation. EMS may need to transport patients to temporary facilities or directly to the most appropriate facility based on local resources. Fleet resources may become limited while ambulances are being decontaminated and restocked with supplies. Appropriate delays in EMS first medical contact are to be expected as essential precautionary measures are required to minimize COVID-19 exposure and transmission. Necessary delays after hospital arrival occur related to new triage protocols requiring personal travel history, additional detailed sign and symptom screening, thoughtful patient assignment based on suspicion of being COVID-19 positive, and new catheterization laboratory preparations/readiness treating patients in full personal protective equipment (PPE).Interim Emergency STEMI Systems of Care GuidancePublic Awareness/Call 911Although the United States is in the midst of the coronavirus crisis, public awareness campaigns are needed to remind individuals of the signs and symptoms of heart attack, with an added emphasis on calling 911 as soon as possible. Patients must be reassured that appropriate precautions are being taken to protect them and healthcare workers from COVID-19. Earlier entry into the system of care will help offset the expected delays in care.Prehospital/Emergency Medical ServicesIn attempts to mitigate exposure, the Centers for Disease Control and Prevention recommend Emergency Medical Dispatch centers or 911 Public Safety Answering Points dispatchers triage callers, utilizing a series of questions to identify patients (and anyone in the home) who may be experiencing coronavirus signs and symptoms and share this information with prehospital first responders.3Before arrival at the scene, EMS should don the appropriate PPE that must be available to all EMS personnel. Once on scene, the EMS provider should screen the patient again to identify high-risk features. If possible, limiting the number of EMS providers evaluating the patient is recommended. EMS should assume that all patients, regardless of dispatch complaint, may have COVID-19. Minimum recommended PPE for all patient encounters is a surgical mask, eye protection, and gloves. For patients who are deemed to be at high risk for COVID-19, additional PPE is warranted.Once EMS has made rapid but safe and protected contact with the patient, acquisition of the 12-lead ECG should be expedited with subsequent interpretation and prompt notification of findings (and likelihood of COVID-19 infection) to the emergency department. For diagnostic ST elevation, prehospital catheterization laboratory activation should occur immediately. However, often prehospital activation requires more thoughtfulness, coordination, and judgment with particular attention to possible STEMI mimics and duration of symptoms.Emergency DepartmentFor patients presenting through EMS from the field, there should be a standard brief stop in the receiving hospital emergency department before proceeding to the catheterization laboratory, with clear communication between the emergency department physician and the interventional cardiologist. Patients should be triaged for consideration of placement to COVID-positive or suspect and COVID-negative areas. Testing for COVID-19 should not delay primary percutaneous coronary intervention (PCI) for those with clear STEMI. Point-of-care ultrasound use may be helpful to delineate left ventricular wall motion abnormality and pulmonary pathology, particularly in suspected STEMI mimics. Patients who require mechanical ventilation should be intubated before transport to the catheterization laboratory with a lower than usual threshold to avoid aerosol spread of respiratory secretions.Fibrinolytic administration for patients with true STEMI who cannot receive PCI and coronary reperfusion within 120 minutes when transferred from a STEMI referring-hospital should be considered, consistent with guideline recommendations.4 Absent significant system resource constraints, PCI should remain the primary and preferred reperfusion strategy for patients with classic STEMI based on superior outcomes with PCI including preservation of left ventricular function and lower rates of reinfarction, stroke, and death and in view of the higher prevalence of STEMI mimics.Catheterization LaboratoryConsideration should be given to options to safely increase catheterization laboratory readiness to accept patients with STEMI more quickly from the field and emergency department once screened for coronavirus. Designation of 1 laboratory for patients who have tested positive for COVID-19, stocked only with the essential equipment needed for all procedures, may be helpful. Consideration should be given to use of a negative pressure room, limiting staff in the room, and terminal cleaning with possibly a longer 4- to 6-hour clean. Because 25% to 50% of patients infected with SARS-CoV-2 are asymptomatic,5 catheterization laboratory personnel should assume that all patients are COVID-19 positive, particularly in high prevalence areas, and don appropriate PPE.Postreperfusion Hospital CareTriaging patients to proper units after primary PCI is important. In uncomplicated cases, disposition to a noncritical care bed should be considered to conserve critical care beds for patients with COVID-19 requiring mechanical ventilation or critical care unit care. Patients should receive the usual care after myocardial infarction including adherence to guideline directed medical therapy and post–myocardial infarction assessment of left ventricular function with echocardiography. When hospital beds are in extreme demand, early discharge between 24 to 48 hours after PCI in patients with uncomplicated STEMI may be considered.STEMI System of Care Guideline AdherenceThe American College of Cardiology (ACC)/AHA STEMI Guideline recommendations continue to provide the foundation of our evidence-based therapies and efforts to meet time-sensitive goals should continue.4 However, during this COVID-19 pandemic, the inherent delays should be considered as nonsystem delays in the context of reporting measures.Postdischarge CareTelemedicineBecause of the COVID-19 crisis, the value of telemedicine can surge in (STEMI) heart attack systems of care consultation and management. Coordination of care between STEMI receiving centers, with EMS, and with STEMI referring hospitals may benefit from telemedicine capabilities. Telemedicine can also help with family communications for patients with STEMI, as many family members are prohibited from entering the hospital.Cardiac RehabilitationStay-at-home orders and social distancing guidelines have and will continue to have an effect on cardiac rehabilitation opportunities. Cardiac rehabilitation can be attended in a healthcare facility–based program or a home health or virtual model, and referral should still be made to a program to facilitate enrollment at a later date.SummaryDespite the effect of the COVID-19 pandemic on STEMI Systems of Care (Figure), evidence-based cardiac care and the tenets of our collective systems of care success should not be abandoned. Regionalization of STEMI care is perhaps more important than ever. Communication between hospitals and EMS and interfacility transport providers in a region, sharing protocols, resources, data, and experiences may prove critically important. Usual monthly review meetings should continue through the pandemic, in a virtual format, to review regional performance and opportunities for improvement.Download figureDownload PowerPointFigure. Potential Effect of the COVID-19 Pandemic on STEMI Systems of Care EMS indicates emergency medical services; ER, emergency room; COVID-19, coronavirus disease 2019; MI, myocardial infarction; PCI, percutaneous coronary intervention; PPE, personal protective equipment; STEMI, ST-segment–elevation myocardial infarction.DisclosuresThe Get With The Guidelines Coronary Artery Disease (GWTG-CAD) program is provided by the American Heart Association. GWTG-CAD is sponsored, in part, by Novartis, Edwards, and Amgen Cardiovascular. Dr Bieniarz reports consulting for Terumo and Abiomed, and consulting and speakers bureau for Amgen. Dr Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Edwards, Janssen, Medtronic, Merck, and Novartis. Dr Granger reports no conflicts relevant to the current work. Dr Jacobs is a site principal investigator for a trial by Abbott Vascular. Dr Zègre-Hemsey receives funding through the US National Institutes of Health. Drs Ali, Best, Cohen, Goyal, Henry, Hollowell, Jneid, Jollis, Katz, Mason, Menon, Redlener, and Tamis-Holland have no relevant relationships to disclose.AppendixAlice K. Jacobs, MD; Murtuza Ali, MD; Patricia J. Best, MD; Mark Bieniarz, MD; Mauricio G. Cohen, MD; William J. French, MD; Gregg C. Fonarow, MD; Christopher B. Granger, MD; Abhinav Goyal, MD; Timothy D. Henry, MD; Lori Hollowell, RN, MHIT; Hani Jneid, MD; James G. Jollis, MD; Jason N. Katz, MD, MHS; Peter Mason, MD, MPH; Venu Menon, MD; Michael Redlener, MD; Jacqueline E. Tamis-Holland, MD; Jessica Zegre-Hemsey, PhD, RN; On behalf of the American Heart Association’s Mission: Lifeline and Get With The Guidelines Coronary Artery Disease Advisory Work Group and the Council on Clinical Cardiology’s Committees on Acute Cardiac Care and General Cardiology and Interventional Cardiovascular Care.*Footnotes*Endorsed by the AHA Council on Clinical CardiologyThe opinions expressed in this article are not necessarily those of the editors.https://www.ahajournals.org/journal/circAlice K. Jacobs, MD, Section of Cardiology, Boston Medical Center, 72 East Concord Street, Boston, MA 02118. Email alice.jacobs@bmc.orgReferences1. Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients: executive summary.Circulation. 2007; 116:217–230. doi: 10.1161/CIRCULATIONAHA.107.184043LinkGoogle Scholar2. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ, Tannenbaum M, Chambers J, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic.J Am Coll Cardiol. 2020; 75:2871–2872. doi: 10.1016/j.jacc.2020.04.011CrossrefMedlineGoogle Scholar3. Centers for Disease Control and Prevention. Interim Guidance for Emergency Medical Services (EMS) Systems and 911 Public Safety Answering Points (PSAPs) for COVID-19 in the United States.Updated March 10, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-for-ems.html. Accessed April 11, 2020.Google Scholar4. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2013; 127:e362–e425. doi: 10.1161/CIR.0b013e3182742cf6LinkGoogle Scholar5. Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, et al; Public Health–Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility.N Engl J Med. 2020; 382:2081–2090. doi: 10.1056/NEJMoa2008457CrossrefMedlineGoogle Scholar eLetters(0) eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate. Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page. Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Black J, Lees C, Chapman N, Kelleher L, Campbell J, Otahal P, Cheng K, Marwick T and Sharman J (2023) Telehealth Rapid Access Chest Pain Clinic: Initial Experience During COVID-19 Pandemic, Telemedicine and e-Health, 10.1089/tmj.2022.0493, 29:10, (1476-1483), Online publication date: 1-Oct-2023. Romano L, Spaccarotella C, Indolfi C and Curcio A (2023) Revascularization and Left Ventricular Dysfunction for ICD Eligibility, Life, 10.3390/life13091940, 13:9, (1940) Guddeti R, Yildiz M, Nayak K, Alraies M, Davidson L, Henry T and Garcia S (2023) Impact of COVID-19 on Acute Myocardial Infarction Care, Heart Failure Clinics, 10.1016/j.hfc.2022.08.004, 19:2, (221-229), Online publication date: 1-Apr-2023. Drapkina O, Kravchenko A, Budnevskiy A, Kontsevaya A, Ovsyannikov E and Drobysheva E (2023) Acute Coronary Syndrome during the Pandemic New Coronavirus Infection, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2023-01-04, 19:1, (65-70) Akinrinmade A, Obitulata-Ugwu V, Obijiofor N, Victor F, Chive M, Marwizi F, Odion-Omonhimin L and Obasi N COVID-19 and Acute Coronary Syndrome: A Literature Review, Cureus, 10.7759/cureus.29747 Guddeti R, Yildiz M, Nayak K, Alraies M, Davidson L, Henry T and Garcia S (2022) Impact of COVID-19 on Acute Myocardial Infarction Care, Cardiology Clinics, 10.1016/j.ccl.2022.03.004, 40:3, (345-353), Online publication date: 1-Aug-2022. AYDIN H, BEŞTEMİR A, BOZDERELİ BERİKOL G and DOĞAN H (2022) Pandemi Hastanesinin Acil Servisine Başvuran Hastaların Analizi: Bir Retrospektif Türkiye Çalışması, Tıbbi Sosyal Hizmet Dergisi, 10.46218/tshd.1106381, 0:19, (76-85) Dengler J, Prass K, Palm F, Hohenstein S, Pellisier V, Stoffel M, Hong B, Meier-Hellmann A, Kuhlen R, Bollmann A and Rosahl S (2022) Changes in nationwide in-hospital stroke care during the first four waves of COVID-19 in Germany, European Stroke Journal, 10.1177/23969873221089152, 7:2, (166-174), Online publication date: 1-Jun-2022. Bhatt A, Varshney A, Goodrich E, Gong J, Ginder C, Senman B, Johnson M, Butler K, Woolley A, de Lemos J, Morrow D and Bohula E (2022) Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry, Journal of the American Heart Association, 11:9, Online publication date: 3-May-2022. Güler A, Gürbak İ, Panç C, Güner A and Ertürk M (2021) Frequency and predictors of no-reflow phenomenon in patients with COVID-19 presenting with ST-segment elevation myocardial infarction, Acta Cardiologica, 10.1080/00015385.2021.1931638, 77:4, (313-321), Online publication date: 21-Apr-2022. Zhou S, Dong X, Liu F, Zhang Y, Yue D, Zhou Q, Jin Y and Zheng Z (2021) A stepped wedge cluster randomized control trial to evaluate the implementation and effectiveness of optimized initiatives in improving quality of care for ST segment elevation myocardial infarction in response to the COVID-19 outbreak, Implementation Science, 10.1186/s13012-021-01107-1, 16:1, Online publication date: 1-Dec-2021. Jacobs A, Ali M, Best P, Bieniarz M, Bufalino V, French W, Henry T, Hollowell L, Jauch E, Kurz M, Levy M, Patel P, Spier T, Stone R, Tataris K, Thomas R and Zègre-Hemsey J (2021) Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart Association, Circulation, 144:20, (e310-e327), Online publication date: 16-Nov-2021. Yildiz M, Wade S and Henry T (2021) STEMI care 2021: Addressing the knowledge gaps, American Heart Journal Plus: Cardiology Research and Practice, 10.1016/j.ahjo.2021.100044, 11, (100044), Online publication date: 1-Nov-2021. Sud M, Qiu F, Shah R, Lee D, Nallamothu B, Natarajan M, Wijeysundera H and Ko D (2021) Rate of COVID-19 Infection in Patients With ST-Segment Elevation Myocardial Infarction, CJC Open, 10.1016/j.cjco.2021.05.012, 3:10, (1214-1216), Online publication date: 1-Oct-2021. Manolis A, Manolis A, Manolis T and Melita H (2021) COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/10742484211011026, 26:5, (399-414), Online publication date: 1-Sep-2021. Lavoie M, Ramirez A and Kunz J (2021) A Unique Case of COVID-19-related Acute Coronary Thrombosis Complicated by Severe Hypokalemia, Military Medicine, 10.1093/milmed/usab100, 186:9-10, (e1053-e1057), Online publication date: 28-Aug-2021. Mao Q, Zhao J, Li Y, Xie L, Xiao H, Wang K, Qiu Y, Chen J, Xu Q, Xu Z, Yu Y, Zhang Y, Li Q, Pang X, Li Z, Ran B, Zhang Z, Li Z, Zeng C, Tong S, Jin J, Huang L and Zhao X (2021) Impact of COVID-19 Pandemic on Mechanical Reperfusion in ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Multicenter Retrospective Study From a Non-epicenter Region, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.698923, 8 Nogueira R, Abdalkader M, Qureshi M, Frankel M, Mansour O, Yamagami H, Qiu Z, Farhoudi M, Siegler J, Yaghi S, Raz E, Sakai N, Ohara N, Piotin M, Mechtouff L, Eker O, Chalumeau V, Kleinig T, Pop R, Liu J, Winters H, Shang X, Vasquez A, Blasco J, Arenillas J, Martinez-Galdamez M, Brehm A, Psychogios M, Lylyk P, Haussen D, Al-Bayati A, Mohammaden M, Fonseca L, Luís Silva M, Montalverne F, Renieri L, Mangiafico S, Fischer U, Gralla J, Frei ,, Chugh C, Mehta B, Nagel S, Mohlenbruch M, Ortega-Gutierrez S, Farooqui M, Hassan A, Taylor A, Lapergue B, Consoli A, Campbell B, Sharma M, Walker M, Van Horn N, Fiehler J, Nguyen H, Nguyen Q, Watanabe D, Zhang H, Le H, Nguyen V, Shah R, Devlin T, Khandelwal P, Linfante I, Izzath W, Lavados P, Olavarría V, Sampaio Silva G, de Carvalho Sousa A, Kirmani J, Bendszus M, Amano T, Yamamoto R, Doijiri R, Tokuda N, Yamada T, Terasaki T, Yazawa Y, Morris J, Griffin E, Thornton J, Lavoie P, Matouk C, Hill M, Demchuk A, Killer-Oberpfalzer M, Nahab F, Altschul D, Ramos-Pachón A, Pérez de la Ossa N, Kikano R, Boisseau W, Walker G, Cordina S, Puri A, Luisa Kuhn A, Gandhi D, Ramakrishnan P, Novakovic-White R, Chebl A, Kargiotis O, Czap A, Zha A, Masoud H, Lopez C, Ozretic D, Al-Mufti F, Zie W, Duan Z, Yuan Z, Huang W, Hao Y, Luo J, Kalousek V, Bourcier R, Guile R, Hetts S, Al-Jehani H, AlHazzani A, Sadeghi-Hokmabadi E, Teleb M, Payne J, Lee J, Hong J, Sohn S, Hwang Y, Shin D, Roh H, Edgell R, Khatri R, Smith A, Malik A, Liebeskind D, Herial N, Jabbour P, Magalhaes P, Ozdemir A, Aykac O, Uwatoko T, Dembo T, Shimizu H, Sugiura Y, Miyashita F, Fukuda H, Miyake K, Shimbo J, Sugimura Y, Beer-Furlan A, Joshi K, Catanese L, Abud D, Neto O, Mehrpour M, Al Hashmi A, Saqqur M, Mostafa A, Fifi J, Hussain S, John S, Gupta R, Sivan-Hoffmann R, Reznik A, Sani A, Geyik S, Akıl E, Churojana A, Ghoreishi A, Saadatnia M, Sharifipour E, Ma A, Faulder K, Wu T, Leung L, Malek A, Voetsch B, Wakhloo A, Rivera R, Barrientos Iman D, Pikula A, Lioutas V, Thomalla G, Birnbaum L, Machi P, Bernava G, McDermott M, Kleindorfer D, Wong K, Patterson M, Fiorot J, Huded V, Mack W, Tenser M, Eskey C, Multani S, Kelly M, Janardhan V, Cornett O, Singh V, Murayama Y, Mokin M, Yang P, Zhang X, Yin C, Han H, Peng Y, Chen W, Crosa R, Frudit M, Pandian J, Kulkarni A, Yagita Y, Takenobu Y, Matsumaru Y, Yamada S, Kono R, Kanamaru T, Yamazaki H, Sakaguchi M, Todo K, Yamamoto N, Sonoda K, Yoshida T, Hashimoto H, Nakahara I, Cora E, Volders D, Ducroux C, Shoamanesh A, Ospel J, Kaliaev A, Ahmed S, Rashid U, Rebello L, Pereira V, Fahed R, Chen M, Sheth S, Palaiodimou L, Tsivgoulis G, Chandra R, Koyfman F, Leung T, Khosravani H, Dharmadhikari S, Frisullo G, Calabresi P, Tsiskaridze A, Lobjanidze N, Grigoryan M, Czlonkowska A, de Sousa D, Demeestere J, Liang C, Sangha N, Lutsep H, Ayo-Martín Ó, Cruz-Culebras A, Tran A, Young C, Cordonnier C, Caparros F, De Lecinana M, Fuentes B, Yavagal D, Jovin T, Spelle L, Moret J, Khatri P, Zaidat O, Raymond J, Martins S and Nguyen T (2021) Global impact of COVID-19 on stroke care, International Journal of Stroke, 10.1177/1747493021991652, 16:5, (573-584), Online publication date: 1-Jul-2021. Nogueira R, Qureshi M, Abdalkader M, Martins S, Yamagami H, Qiu Z, Mansour O, Sathya A, Czlonkowska A, Tsivgoulis G, Aguiar de Sousa D, Demeestere J, Mikulik R, Vanacker P, Siegler J, Kõrv J, Biller J, Liang C, Sangha N, Zha A, Czap A, Holmstedt C, Turan T, Ntaios G, Malhotra K, Tayal A, Loochtan A, Ranta A, Mistry E, Alexandrov A, Huang D, Yaghi S, Raz E, Sheth S, Mohammaden M, Frankel M, Bila Lamou E, Aref H, Elbassiouny A, Hassan F, Menecie T, Mustafa W, Shokri H, Roushdy T, Sarfo F, Alabi T, Arabambi B, Nwazor E, Sunmonu T, Wahab K, Yaria J, Mohammed H, Adebayo P, Riahi A, Sassi S, Gwaunza L, Ngwende G, Sahakyan D, Rahman A, Ai Z, Bai F, Duan Z, Hao Y, Huang W, Li G, Li W, Liu G, Luo J, Shang X, Sui Y, Tian L, Wen H, Wu B, Yan Y, Yuan Z, Zhang H, Zhang J, Zhao W, Zi W, Leung T, Chugh C, Huded V, Menon B, Pandian J, Sylaja P, Usman F, Farhoudi M, Hokmabadi E, Horev A, Reznik A, Sivan Hoffmann R, Ohara N, Sakai N, Watanabe D, Yamamoto R, Doijiri R, Tokuda N, Yamada T, Terasaki T, Yazawa Y, Uwatoko T, Dembo T, Shimizu H, Sugiura Y, Miyashita F, Fukuda H, Miyake K, Shimbo J, Sugimura Y, Yagita Y, Takenobu Y, Matsumaru Y, Yamada S, Kono R, Kanamaru T, Yamazaki H, Sakaguchi M, Todo K, Yamamoto N, Sonoda K, Yoshida T, Hashimoto H, Nakahara I, Kondybayeva A, Faizullina K, Kamenova S, Zhanuzakov M, Baek J, Hwang Y, Lee J, Lee S, Moon J, Park H, Seo J, Seo K, Sohn S, Young C, Ahdab R, Wan Zaidi W, Aziz Z, Basri H, Chung L, Ibrahim A, Ibrahim K, Looi I, Tan W, Yahya N, Groppa S, Leahu P, Al Hashmi A, Imam Y, Akhtar N, Pineda-Franks M, Co C, Kandyba D, Alhazzani A, Al-Jehani H, Tham C, Mamauag M, Venketasubramanian N, Chen C, Tang S, Churojana A, Akil E, aykaç ö, Ozdemir A, Giray S, Hussain S, John S, Le Vu H, Tran A, Nguyen H, Nhu Pham T, Nguyen T, Nguyen T, Gattringer T, Enzinger C, Killer-Oberpfalzer M, Bellante F, De Blauwe S, Vanhooren G, De Raedt S, Dusart A, Lemmens R, Ligot N, Pierre Rutgers M, Yperzeele L, Alexiev F, Sakelarova T, Bedeković M, Budincevic H, Cindric I, Hucika Z, Ozretic D, Saric M, Pfeifer F, Karpowic I, Cernik D, Sramek M, Skoda M, Hlavacova H, Klecka L, Koutny M, Vaclavik D, Skoda O, Fiksa J, Hanelova K, Nevsimalova M, Rezek R, Prochazka P, Krejstova G, Neumann J, Vachova M, Brzezanski H, Hlinovsky D, Tenora D, Jura R, Jurák L, Novak J, Novak A, Topinka Z, Fibrich P, Sobolova H, Volny O, Krarup Christensen H, Drenck N, Klingenberg Iversen H, Simonsen C, Truelsen T, Wienecke T, Vibo R, Gross-Paju K, Toomsoo T, Antsov K, Caparros F, Cordonnier C, Dan M, Faucheux J, Mechtouff L, Eker O, Lesaine E, Ondze B, Peres R, Pico F, Piotin M, Pop R, Rouanet F, Gubeladze T, Khinikadze M, Lobjanidze N, Tsiskaridze A, Nagel S, Ringleb P, Rosenkranz M, Schmidt H, Sedghi A, Siepmann T, Szabo K, Thomalla G, Palaiodimou L, Sagris D, Kargiotis O, Klivenyi P, Szapary L, Tarkanyi G, Adami A, Bandini F, Calabresi P, Frisullo G, Renieri L, Sangalli D, Pirson A, Uyttenboogaart M, van den Wijngaard I, Kristoffersen E, Brola W, Fudala M, Horoch-Lyszczarek E, Karlinski M, Kazmierski R, Kram P, Rogoziewicz M, Kaczorowski R, Luchowski P, Sienkiewicz-Jarosz H, Sobolewski P, Fryze W, Wisniewska A, Wiszniewska M, Ferreira P, Ferreira P, Fonseca L, Marto J, Pinho e Melo T, Nunes A, Rodrigues M, Tedim Cruz V, Falup-Pecurariu C, Krastev G, Mako M, de Leciñana M, Arenillas J, Ayo-Martin O, Cruz Culebras A, Tejedor E, Montaner J, Pérez-Sánchez S, Tola Arribas M, Rodriguez Vasquez A, Mayza M, Bernava G, Brehm A, Machi P, Fischer U, Gralla J, Michel P, Psychogios M, Strambo D, Banerjee S, Krishnan K, Kwan J, Butt A, Catanese L, Demchuk A, Field T, Haynes J, Hill M, Khosravani H, Mackey A, Pikula A, Saposnik G, Scott C, Shoamanesh A, Shuaib A, Yip S, Barboza M, Barrientos J, Portillo Rivera L, Gongora-Rivera F, Novarro-Escudero N, Blanco A, Abraham M, Alsbrook D, Altschul D, Alvarado-Ortiz A, Bach I, Badruddin A, Barazangi N, Brereton C, Castonguay A, Chaturvedi S, Chaudry S, Choe H, Choi J, Dharmadhikari S, Desai K, Devlin T, Doss V, Edgell R, Etherton M, Farooqui M, Frei D, Gandhi D, Grigoryan M, Gupta R, Hassan A, Helenius J, Kaliaev A, Kaushal R, Khandelwal P, Khawaja A, Khoury N, Kim B, Kleindorfer D, Koyfman F, Lee V, Leung L, Linares G, Linfante I, Lutsep H, Macdougall L, Male S, Malik A, Masoud H, McDermott M, Mehta B, Min J, Mittal M, Morris J, Multani S, Nahab F, Nalleballe K, Nguyen C, Novakovic-White R, Ortega-Gutierrez S, Rahangdale R, Ramakrishnan P, Romero J, Rost N, Rothstein A, Ruland S, Shah R, Sharma M, Silver B, Simmons M, Singh A, Starosciak A, Strasser S, Szeder V, Teleb M, Tsai J, Voetsch B, Balaguera O, Pujol Lereis V, Luraschi A, Almeida M, Cardoso F, Conforto A, De Deus Silva L, Varrone Giacomini L, Oliveira Lima F, Longo A, Magalhães P, Martins R, Mont'alverne F, Mora Cuervo D, Costa Rebello L, Valler L, Zetola V, Lavados P, Navia V, Olavarría V, Almeida Toro J, Amaya P, Bayona H, Corredor A, Rivera Ordonez C, Mantilla Barbosa D, Lara O, Patiño M, Diaz Escobar L, Dejesus Melgarejo Fariña D, Cardozo Villamayor A, Zelaya Zarza A, Barrientos Iman D, Rodriguez Kadota L, Campbell B, Hankey G, Hair C, Kleinig T, Ma A, Tomazini Martins R, Sahathevan R, Thijs V, Salazar D, Yuan-Hao Wu T, Haussen D, Liebeskind D, Yavagal D, Jovin T, Zaidat O and Nguyen T (2021) Global Impact of COVID-19 on Stroke Care and IV Thrombolysis, Neurology, 10.1212/WNL.0000000000011885, 96:23, (e2824-e2838), Online publication date: 8-Jun-2021. Borgaonkar S, Hahn J, Daher M, Kayani W and Jneid H (2021) Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era, Current Cardiology Reports, 10.1007/s11886-021-01501-7, 23:6, Online publication date: 1-Jun-2021. Kitakata H, Katsumata Y, Kohsaka S, Sekine O, Kohno T, Sano M and Fukuda K (2021) Patient Perspectives in the Era of Remote Medical Visits During the Coronavirus Disease (COVID-19) Pandemic ― Insights From Outpatient Care of Cardiovascular Disease ―, Circulation Reports, 10.1253/circrep.CR-21-0039, 3:5, (300-303), Online publication date: 10-May-2021. Kermani-Alghoraishi M (2021) A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction, Current Problems in Cardiology, 10.1016/j.cpcardiol.2020.100744, 46:3, (100744), Online publication date: 1-Mar-2021. Kow C and Hasan S (2021) Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic, Journal of the Formosan Medical Association, 10.1016/j.jfma.2020.07.041, 120:1, (772-773), Online publication date: 1-Jan-2021. Reinstadler S, Reindl M, Lechner I, Holzknecht M, Tiller C, Roithinger F, Frick M, Hoppe U, Jirak P, Berger R, Delle-Karth G, Laßnig E, Klug G, Bauer A, Binder R and Metzler B (2020) Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction, Journal of Clinical Medicine, 10.3390/jcm9072183, 9:7, (2183) Schiavone M, Gobbi C, Biondi-Zoccai G, D’Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, Mancone M and Forleo G (2020) Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties, Journal of Clinical Medicine, 10.3390/jcm9061683, 9:6, (1683) July 21, 2020Vol 142, Issue 3 Advertisement Article Information Metrics © 2020 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.120.048180PMID: 32363905 Originally publishedMay 2, 2020 Keywordspercutaneous coronary interventionSTEMIPDF download Advertisement Subjects Myocardial Infarction Percutaneous Coronary Intervention
Referência(s)